Plain-English translation of NCT07317102 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The Omnipod 5 is an automated insulin delivery system that works with a glucose sensor to help manage type 1 diabetes. This study is following people in France who have recently started using the Omnipod 5 to see how well their blood sugar is controlled, how the device performs in everyday use, and how it affects their quality of life over 12 months.
While the Omnipod 5 is already available for patients to use, researchers want to gather real-world information about how well this medication works for different people in France and how it impacts their day-to-day diabetes management.
You likely qualify if…
You likely don't qualify if…
You would use the Omnipod 5 system normally over 12 months while staying in contact with the study clinic. During this time, you would complete questionnaires about your blood sugar control, how the device works for you, and how it affects your quality of life. The study team will track information about your device use and blood sugar readings to understand how well the system is working in real life.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France